Works matching IS 00070920 AND DT 2022 AND VI 127 AND IP 11

Results: 18
    1

    Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.

    Published in:
    2022
    By:
    • Jacot, William;
    • Lusque, Amélie;
    • Vicier, Cécile;
    • Mailliez, Audrey;
    • de La Motte Rouge, Thibault;
    • Cabel, Luc;
    • Levy, Christelle;
    • Patsouris, Anne;
    • Desmoulins, Isabelle;
    • Uwer, Lionel;
    • Thery, Jean-Christophe;
    • Robain, Mathieu;
    • Caron, Olivier;
    • Tredan, Olivier;
    • Filleron, Thomas;
    • Frenel, Jean-Sébastien;
    • Delaloge, Suzette
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9

    Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.

    Published in:
    2022
    By:
    • Schaefer, Inga-Marie;
    • Hemming, Matthew L.;
    • Lundberg, Meijun Z.;
    • Serrata, Matthew P.;
    • Goldaracena, Isabel;
    • Liu, Ninning;
    • Yin, Peng;
    • Paulo, Joao A.;
    • Gygi, Steven P.;
    • George, Suzanne;
    • Morgan, Jeffrey A.;
    • Bertagnolli, Monica M.;
    • Sicinska, Ewa T.;
    • Chu, Chen;
    • Zheng, Shanshan;
    • Mariño-Enríquez, Adrian;
    • Hornick, Jason L.;
    • Raut, Chandrajit P.;
    • Ou, Wen-Bin;
    • Demetri, George D.
    Publication type:
    journal article
    10
    11
    12
    13

    Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.

    Published in:
    2022
    By:
    • Fiorito, Elisa;
    • Szybowska, Patrycja;
    • Haugsten, Ellen M.;
    • Kostas, Michal;
    • Øy, Geir F.;
    • Wiedlocha, Antoni;
    • Singh, Sachin;
    • Nakken, Sigve;
    • Mælandsmo, Gunhild M.;
    • Fletcher, Jonathan A.;
    • Meza-Zepeda, Leonardo A.;
    • Wesche, Jørgen
    Publication type:
    journal article
    14
    15
    16
    17
    18